Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 1

Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2

Authors Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace

Published 15 March 2007 Volume 2007:3(1) Pages 159—164

Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace

Cardiology Service, Walter Reed Army Medical Center, Washington, DC, USA

Background: We previously reported in a placebo-controlled study that extended-release niacin slowed the progression of carotid atherosclerosis when added to statin monotherapy. This analysis examines the relationship between glycemic status and the effects of niacin on common carotid intima-media thickness (CIMT) and HDL cholesterol.

Methods: Post-hoc, subgroup analysis of ARBITER 2, a randomized, placebo-controlled trial of once-daily extended-release niacin (1000 mg) added to background statin therapy in 167 patients (mean age 67 years) with known coronary heart disease. The primary analysis was a comparison of the primary endpoint, the change in CIMT, between participants with either normal glycemic status, diabetes mellitus (DM) or the metabolic syndrome (MS).

Results: Baseline cardiovascular risk variables were significantly worse in those with abnormal glycemic status, particularly among subjects with MS. Niacin increased HDL-C to a similar degree (~20%) across normals, DM and MS. Placebo-treated patients had the greatest CIMT progression, regardless of glycemic status. The lowest progression rate was observed in niacin treated patients with normal glycemic status. Among all niacin treated subjects, there was a significant linear relationship between change in CIMT and change in HDL-C (r = –0.16; p = 0.05), which was of similar magnitude in subgroups with normal glycemic status (r = –0.23; p = 0.08) and DM (r = –0.22; p = 0.17). In those with MS, there was no relationship between changes in HDL and CIMT, (r = 0.11; p = 0.44), whereas blood glucose was positive correlated to change in CIMT (r = 0.30; p = 0.04). In multivariable linear models controlling for MS characteristics and blood glucose changes, only the change in HDL independently predicted change in CIMT.

Conclusions: During niacin treatment, increases in HDL-C are related to changes in CIMT in the setting of both normal glycemic status and diabetes mellitus.

Keywords: atherosclerosis, risk factors, lipids, diabetes mellitus

Download Article [PDF] 

Readers of this article also read:

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA

International Journal of Nanomedicine 2014, 9:4245-4255

Published Date: 4 September 2014

Histologic and apoptotic changes induced by titanium dioxide nanoparticles in the livers of rats

Alarifi S, Ali D, Al-Doaiss AA, Ali BA, Ahmed M, Al-Khedhairy AA

International Journal of Nanomedicine 2013, 8:3937-3943

Published Date: 11 October 2013

Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer

Chen H, Wang L, Yu Q, Qian W, Tiwari D, Yi H, Wang AY, Huang J, Yang L, Mao H

International Journal of Nanomedicine 2013, 8:3781-3794

Published Date: 2 October 2013

Potential and problems in ultrasound-responsive drug delivery systems

Zhao YZ, Du LN, Lu CT, Jin YG, Ge SP

International Journal of Nanomedicine 2013, 8:1621-1633

Published Date: 22 April 2013

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Lonngi M, Houston SK, Murray TG, Sisk RA, Decatur CL, Cavalcante M, Markoe AM

Clinical Ophthalmology 2013, 7:427-435

Published Date: 27 February 2013

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier

Kanwar JR, Sriramoju B, Kanwar RK

International Journal of Nanomedicine 2012, 7:3259-3278

Published Date: 9 July 2012

Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering

Lai JY, Li YT, Cho CH, Yu TC

International Journal of Nanomedicine 2012, 7:1101-1114

Published Date: 23 February 2012

Acute progression of electrophysiologically affected fellow eye in unilaterally symptomatic acute zonal occult outer retinopathy

Kure K, Obata R, Inoue Y, Iriyama A, Yanagi Y

Clinical Ophthalmology 2011, 5:1167-1170

Published Date: 19 August 2011

Correlation between bullying and clinical depression in adolescent patients

Kaltiala-Heino R, Fröjd S

Adolescent Health, Medicine and Therapeutics 2011, 2:37-44

Published Date: 25 March 2011

Potential bias in ophthalmic pharmaceutical clinical trials

Paul Varner

Clinical Ophthalmology 2008, 2:401-411

Published Date: 6 June 2008